144 related articles for article (PubMed ID: 34935240)
21. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
[TBL] [Abstract][Full Text] [Related]
22. A cohort study of interstitial lung diseases in central Denmark.
Hyldgaard C; Hilberg O; Muller A; Bendstrup E
Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of Idiopathic Pulmonary Fibrosis among U.S. Veterans, 2010-2019.
Kaul B; Lee JS; Zhang N; Vittinghoff E; Sarmiento K; Collard HR; Whooley MA
Ann Am Thorac Soc; 2022 Feb; 19(2):196-203. PubMed ID: 34314645
[No Abstract] [Full Text] [Related]
24. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.
Agabiti N; Porretta MA; Bauleo L; Coppola A; Sergiacomi G; Fusco A; Cavalli F; Zappa MC; Vignarola R; Carlone S; Facchini G; Mariotta S; Palange P; Valente S; Pasciuto G; Pezzuto G; Orlandi A; Fusco D; Davoli M; Saltini C; Puxeddu E
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):191-7. PubMed ID: 25363218
[TBL] [Abstract][Full Text] [Related]
26. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis.
Kondoh Y; Suda T; Hongo Y; Yoshida M; Hiroi S; Iwasaki K; Takeshima T; Homma S
Respir Res; 2022 Feb; 23(1):24. PubMed ID: 35135550
[TBL] [Abstract][Full Text] [Related]
28. Occupational exposures and idiopathic pulmonary fibrosis.
Walters GI
Curr Opin Allergy Clin Immunol; 2020 Apr; 20(2):103-111. PubMed ID: 31895128
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic pulmonary fibrosis in Taiwan - a population-based study.
Lai CC; Wang CY; Lu HM; Chen L; Teng NC; Yan YH; Wang JY; Chang YT; Chao TT; Lin HI; Chen CR; Yu CJ; Wang JD
Respir Med; 2012 Nov; 106(11):1566-74. PubMed ID: 22954482
[TBL] [Abstract][Full Text] [Related]
30. Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.
Abramson MJ; Murambadoro T; Alif SM; Benke GP; Dharmage SC; Glaspole I; Hopkins P; Hoy RF; Klebe S; Moodley Y; Rawson S; Reynolds PN; Wolfe R; Corte TJ; Walters EH;
Thorax; 2020 Oct; 75(10):864-869. PubMed ID: 32660982
[TBL] [Abstract][Full Text] [Related]
31. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of idiopathic pulmonary fibrosis in Europe--an update.
Annesi-Maesano I; Nunes H; Duchemann B; Valeyre D; Agabiti N; Saltini C; Porretta MA
Sarcoidosis Vasc Diffuse Lung Dis; 2013 Sep; 30 Suppl 1():6-12. PubMed ID: 24081238
[TBL] [Abstract][Full Text] [Related]
33. Idiopathic Pulmonary Fibrosis and Lung Cancer. A Systematic Review and Meta-analysis.
Brown SW; Dobelle M; Padilla M; Agovino M; Wisnivesky JP; Hashim D; Boffetta P
Ann Am Thorac Soc; 2019 Aug; 16(8):1041-1051. PubMed ID: 30892054
[No Abstract] [Full Text] [Related]
34. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Hopkins RB; Burke N; Fell C; Dion G; Kolb M
Eur Respir J; 2016 Jul; 48(1):187-95. PubMed ID: 27230442
[TBL] [Abstract][Full Text] [Related]
35. The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia.
Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Glaspole I; Moodley Y; Goh N; Macansh S; Walters EH; Palmer AJ
Qual Life Res; 2021 Sep; 30(9):2615-2632. PubMed ID: 33999322
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
37. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
38. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Raghu G; Chen SY; Hou Q; Yeh WS; Collard HR
Eur Respir J; 2016 Jul; 48(1):179-86. PubMed ID: 27126689
[TBL] [Abstract][Full Text] [Related]
39. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
[TBL] [Abstract][Full Text] [Related]
40. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.
Kaunisto J; Kelloniemi K; Sutinen E; Hodgson U; Piilonen A; Kaarteenaho R; Mäkitaro R; Purokivi M; Lappi-Blanco E; Saarelainen S; Kankaanranta H; Mursu A; Kanervisto M; Salomaa ER; Myllärniemi M
BMC Pulm Med; 2015 Aug; 15():92. PubMed ID: 26285574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
